2-Oxoglutarate-Dependent Oxygenases

Literature Cited

1. 1.  Myllyharju J. 2015. Collagen hydroxylases. See Ref. 2 149–68
2. 2.  Hausinger RP, Schofield CJ 2015. 2-Oxoglutarate-Dependent Oxygenases Cambridge, UK: R. Soc. Chem
3. 3.  Hausinger RP. 2015. Biochemical diversity of 2-oxoglutarate-dependent oxygenases. See Ref. 2 1–58
4. 4.  Smith JL, Khare D 2015. Recent advances in the structural and mechanistic biology of non-haem Fe(II), 2-oxoglutarate and O₂-dependent halogenases. See Ref. 2 401–13
5. 5.  Hausinger RP. 2004. FeII/α-ketoglutarate-dependent hydroxylases and related enzymes. Crit. Rev. Biochem. Mol. Biol. 39:21–68
   [Google Scholar]
6. 6.  Walport LJ, Hopkinson RJ, Schofield CJ 2012. Mechanisms of human histone and nucleic acid demethylases. Curr. Opin. Chem. Biol. 16:525–34
   [Google Scholar]
7. 7.  Aik WS, Chowdhury R, Clifton IJ, Hopkinson RJ, Leissing T et al. 2015. Introduction to structural studies on 2-oxoglutarate-dependent oxygenases and related enzymes. See Ref. 2 59–94
8. 8.  Clifton IJ, McDonough MA, Ehrismann D, Kershaw NJ, Granatino N, Schofield CJ 2006. Structural studies on 2-oxoglutarate oxygenases and related double-stranded β-helix fold proteins. J. Inorg. Biochem. 100:644–69
   [Google Scholar]
9. 9.  Markolovic S, Leissing TM, Chowdhury R, Wilkins SE, Lu X, Schofield CJ 2016. Structure-function relationships of human JmjC oxygenases-demethylases versus hydroxylases. Curr. Opin. Struct. Biol. 41:62–72
   [Google Scholar]
10. 10.  McDonough MA, Loenarz C, Chowdhury R, Clifton IJ, Schofield CJ 2010. Structural studies on human 2-oxoglutarate dependent oxygenases. Curr. Opin. Struct. Biol. 20:659–72
    [Google Scholar]
11. 11.  Valegard K, van Scheltinga AC, Lloyd MD, Hara T, Ramaswamy S et al. 1998. Structure of a cephalosporin synthase. Nature 394:805–9
    [Google Scholar]
12. 12.  Elkins JM, Ryle MJ, Clifton IJ, Dunning Hotopp JC, Lloyd JS et al. 2002. X-ray crystal structure of Escherichia coli taurine/α-ketoglutarate dioxygenase complexed to ferrous iron and substrates. Biochemistry 41:5185–92
    [Google Scholar]
13. 13.  Zhang Z, Ren J, Stammers DK, Baldwin JE, Harlos K, Schofield CJ 2000. Structural origins of the selectivity of the trifunctional oxygenase clavaminic acid synthase. Nat. Struct. Biol. 7:127–33
    [Google Scholar]
14. 14.  Klose RJ, Kallin EM, Zhang Y 2006. JmjC-domain-containing proteins and histone demethylation. Nat. Rev. Genet. 7:715–27
    [Google Scholar]
15. 15.  Chowdhury R, Sekirnik R, Brissett NC, Krojer T, Ho CH et al. 2014. Ribosomal oxygenases are structurally conserved from prokaryotes to humans. Nature 510:422–26
    [Google Scholar]
16. 16.  Aik W, McDonough MA, Thalhammer A, Chowdhury R, Schofield CJ 2012. Role of the jelly-roll fold in substrate binding by 2-oxoglutarate oxygenases. Curr. Opin. Struct. Biol. 22:691–700
    [Google Scholar]
17. 17.  Horton JR, Upadhyay AK, Qi HH, Zhang X, Shi Y, Cheng X 2010. Enzymatic and structural insights for substrate specificity of a family of jumonji histone lysine demethylases. Nat. Struct. Mol. Biol. 17:38–43
    [Google Scholar]
18. 18.  Loenarz C, Ge W, Coleman ML, Rose NR, Cooper CD et al. 2010. PHF8, a gene associated with cleft lip/palate and mental retardation, encodes for an N^ε-dimethyl lysine demethylase. Hum. Mol. Genet. 19:217–22
    [Google Scholar]
19. 19.  Anantharajan J, Koski MK, Kursula P, Hieta R, Bergmann U et al. 2013. The structural motifs for substrate binding and dimerization of the α subunit of collagen prolyl 4-hydroxylase. Structure 21:2107–18
    [Google Scholar]
20. 20.  Hanauske-Abel HM, Gunzler V 1982. A stereochemical concept for the catalytic mechanism of prolylhydroxylase: applicability to classification and design of inhibitors. J. Theor. Biol. 94:421–55
    [Google Scholar]
21. 21.  Bollinger JM Jr, Chang W-C, Matthews ML, Martinie RJ, Boal AK, Krebs C. 2015. Mechanisms of 2-oxoglutarate-dependent oxygenases: the hydroxylation paradigm and beyond. See Ref. 2 95–122
22. 22.  Gronke RS, VanDusen WJ, Garsky VM, Jacobs JW, Sardana MK et al. 1989. Aspartyl β-hydroxylase: in vitro hydroxylation of a synthetic peptide based on the structure of the first growth factor-like domain of human factor IX. PNAS 86:3609–13
    [Google Scholar]
23. 23.  Galonic DP, Vaillancourt FH, Walsh CT 2006. Halogenation of unactivated carbon centers in natural product biosynthesis: trichlorination of leucine during barbamide biosynthesis. J. Am. Chem. Soc. 128:3900–1
    [Google Scholar]
24. 24.  Pasini D, Cloos PA, Walfridsson J, Olsson L, Bukowski JP et al. 2010. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 464:306–10
    [Google Scholar]
25. 25.  Chan MC, Holt-Martyn JP, Schofield CJ, Ratcliffe PJ 2016. Pharmacological targeting of the HIF hydroxylases—a new field in medicine development. Mol. Asp. Med. 47–48:54–75
    [Google Scholar]
26. 26.  Chowdhury R, Leung IK, Tian YM, Abboud MI, Ge W et al. 2016. Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases. Nat. Commun. 7:12673
    [Google Scholar]
27. 27.  Chowdhury R, McDonough MA, Mecinovic J, Loenarz C, Flashman E et al. 2009. Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases. Structure 17:981–89
    [Google Scholar]
28. 28.  Ng SS, Kavanagh KL, McDonough MA, Butler D, Pilka ES et al. 2007. Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity. Nature 448:87–91
    [Google Scholar]
29. 29.  Price JC, Barr EW, Glass TE, Krebs C, Bollinger JM Jr 2003. Evidence for hydrogen abstraction from C1 of taurine by the high-spin Fe(IV) intermediate detected during oxygen activation by taurine:α-ketoglutarate dioxygenase (TauD). J. Am. Chem. Soc. 125:13008–9
    [Google Scholar]
30. 30.  Costas M, Mehn MP, Jensen MP, Que L Jr 2004. Dioxygen activation at mononuclear nonheme iron active sites: enzymes, models, and intermediates. Chem. Rev. 104:939–86
    [Google Scholar]
31. 31.  Mitchell AJ, Dunham NP, Martinie RJ, Bergman JA, Pollock CJ et al. 2017. Visualizing the reaction cycle in an iron(II)- and 2-(oxo)-glutarate-dependent hydroxylase. J. Am. Chem. Soc. 139:13830–36
    [Google Scholar]
32. 32.  Hamed RB, Gomez-Castellanos JR, Henry L, Ducho C, McDonough MA, Schofield CJ 2013. The enzymes of β-lactam biosynthesis. Nat. Prod. Rep. 30:21–107
    [Google Scholar]
33. 33.  Tarhonskaya H, Szollossi A, Leung IK, Bush JT, Henry L et al. 2014. Studies on deacetoxycephalosporin C synthase support a consensus mechanism for 2-oxoglutarate dependent oxygenases. Biochemistry 53:2483–93
    [Google Scholar]
34. 34.  Rose NR, McDonough MA, King ONF, Kawamura A, Schofield CJ 2011. Inhibition of 2-oxoglutarate dependent oxygenases. Chem. Soc. Rev. 40:4364–97
    [Google Scholar]
35. 35.  Mantri M, Zhang Z, McDonough MA, Schofield CJ 2012. Autocatalysed oxidative modifications to 2-oxoglutarate dependent oxygenases. FEBS J 279:1563–75
    [Google Scholar]
36. 36.  Rutledge PJ. 2015. Isopenicillin N synthase. See Ref. 2 414–24
37. 37.  Chowdhury R, Candela-Lena JI, Chan MC, Greenald DJ, Yeoh KK et al. 2013. Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases. ACS Chem. Biol. 8:1488–96
    [Google Scholar]
38. 38.  Flashman E, Bagg EAL, Chowdhury R, Mecinović J, Loenarz C et al. 2008. Kinetic rationale for selectivity toward N- and C-terminal oxygen-dependent degradation domain substrates mediated by a loop region of hypoxia-inducible factor prolyl hydroxylases. J. Biol. Chem. 283:3808–15
    [Google Scholar]
39. 39.  Scotti JS, Leung IK, Ge W, Bentley MA, Paps J et al. 2014. Human oxygen sensing may have origins in prokaryotic elongation factor Tu prolyl-hydroxylation. PNAS 111:13331–36
    [Google Scholar]
40. 40.  Muller TA, Hausinger RP 2015. AlkB and its homologues—DNA repair and beyond. See Ref. 2 246–62
41. 41.  Bleijlevens B, Shivarattan T, Flashman E, Yang Y, Simpson PJ et al. 2008. Dynamic states of the DNA repair enzyme AlkB regulate product release. EMBO Rep 9:872–77
    [Google Scholar]
42. 42.  Kelly L, McDonough MA, Coleman ML, Ratcliffe PJ, Schofield CJ 2009. Asparagine β-hydroxylation stabilizes the ankyrin repeat domain fold. Mol. Biosyst. 5:52–58
    [Google Scholar]
43. 43.  Schofield CJ, Ratcliffe PJ 2005. Signalling hypoxia by HIF hydroxylases. Biochem. Biophys. Res. Commun. 338:617–26
    [Google Scholar]
44. 44.  Chin RM, Fu X, Pai MY, Vergnes L, Hwang H et al. 2014. The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature 510:397–401
    [Google Scholar]
45. 45.  Nowicki S, Gottlieb E 2015. Oncometabolites: tailoring our genes. FEBS J 282:2796–805
    [Google Scholar]
46. 46.  Lindstedt G, Lindstedt S, Nordin I 1982. γ-Butyrobetaine hydroxylase in human kidney. Scand. J. Clin. Lab. Invest. 42:477–85
    [Google Scholar]
47. 47.  Vaz FM, van Vlies N 2015. Dioxygenases of carnitine biosynthesis: 6-N-trimethyllysine and γ-butyrobetaine hydroxylases. See Ref. 2 324–37
48. 48.  Berk L, Burchenal JH, Castle WB 1949. Erythropoietic effect of cobalt in patients with or without anemia. N. Engl. J. Med. 240:754–61
    [Google Scholar]
49. 49.  Salahudeen AA, Thompson JW, Ruiz JC, Ma H-W, Kinch LN et al. 2009. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis. Science 326:722–26
    [Google Scholar]
50. 50.  Clarke HT. 1952. Henry Drysdale Dakin, 1880–1952. J. Biol. Chem. 198:491–94
    [Google Scholar]
51. 51.  Ruotsalainen H, Risteli M, Wang C, Wang Y, Karppinen M et al. 2012. The activities of lysyl hydroxylase 3 (LH3) regulate the amount and oligomerization status of adiponectin. PLOS ONE 7:e50045
    [Google Scholar]
52. 52.  Shoulders MD, Raines RT 2009. Collagen structure and stability. Annu. Rev. Biochem. 78:929–58
    [Google Scholar]
53. 53.  Aihara A, Huang CK, Olsen MJ, Lin Q, Chung W et al. 2014. A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma. Hepatology 60:1302–13
    [Google Scholar]
54. 54.  Patel N, Khan AO, Mansour A, Mohamed JY, Al-Assiri A et al. 2014. Mutations in ASPH cause facial dysmorphism, lens dislocation, anterior-segment abnormalities, and spontaneous filtering blebs, or Traboulsi syndrome. Am. J. Hum. Gen. 94:755–59
    [Google Scholar]
55. 55.  Loenarz C, Schofield CJ 2011. Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases. Trends. Biochem. Sci. 36:7–18
    [Google Scholar]
56. 56.  Jiang BH, Rue E, Wang GL, Roe R, Semenza GL 1996. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271:17771–78
    [Google Scholar]
57. 57.  Chowdhury R, Hardy A, Schofield CJ 2008. The human oxygen sensing machinery and its manipulation. Chem. Soc. Rev. 37:1308–19
    [Google Scholar]
58. 58.  Kaelin WG Jr, Ratcliffe PJ. 2008. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30:393–402
    [Google Scholar]
59. 59.  Semenza GL, Wang GL 1992. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell Biol. 12:5447–54
    [Google Scholar]
60. 60.  Wang GL, Jiang BH, Rue EA, Semenza GL 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O₂ tension. PNAS 92:5510–14
    [Google Scholar]
61. 61.  Bruick RK, McKnight SL 2001. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294:1337–40
    [Google Scholar]
62. 62.  Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J et al. 2001. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43–54
    [Google Scholar]
63. 63.  Ivan M, Kondo K, Yang H, Kim W, Valiando J et al. 2001. HIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O₂ sensing. Science 292:464–68
    [Google Scholar]
64. 64.  Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J et al. 2001. Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O₂-regulated prolyl hydroxylation. Science 292:468–72
    [Google Scholar]
65. 65.  Hewitson KS, McNeill LA, Riordan MV, Tian YM, Bullock AN et al. 2002. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277:26351–55
    [Google Scholar]
66. 66.  Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK 2002. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16:1466–71
    [Google Scholar]
67. 67.  Chowdhury R, Leung IKH, Tian Y-M, Abboud MI, Ge W et al. 2016. Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases. Nat. Commun. 7:12673
    [Google Scholar]
68. 68.  Loenarz C, Coleman ML, Boleininger A, Schierwater B, Holland PW et al. 2011. The hypoxia-inducible transcription factor pathway regulates oxygen sensing in the simplest animal. Trichoplax adhaerens. EMBO Rep. 12:63–70
    [Google Scholar]
69. 69.  West CM, Blader IJ 2015. Oxygen sensing by protozoans: how they catch their breath. Curr. Opin. Microbiol. 26:41–47
    [Google Scholar]
70. 70.  Chan MC, Ilott NE, Schödel J, Sims D, Tumber A et al. 2016. Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases. J. Biol. Chem. 291:20661–73
    [Google Scholar]
71. 71.  Flashman E, Hoffart LM, Hamed RB, Bollinger JM Jr, Krebs C, Schofield CJ 2010. Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen. FEBS J 277:4089–99
    [Google Scholar]
72. 72.  Tarhonskaya H, Hardy AP, Howe EA, Loik ND, Kramer HB et al. 2015. Kinetic investigations of the role of factor inhibiting hypoxia-inducible factor (FIH) as an oxygen sensor. J. Biol. Chem. 290:19726–42
    [Google Scholar]
73. 73.  Tian Y-M, Yeoh KK, Lee MK, Eriksson T, Kessler BM et al. 2011. Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors. J. Biol. Chem. 286:13041–51
    [Google Scholar]
74. 74.  Cockman ME, Webb JD, Kramer HB, Kessler BM, Ratcliffe PJ 2009. Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins. Mol. Cell Proteom. 8:535–46
    [Google Scholar]
75. 75.  Hardy AP, Prokes I, Kelly L, Campbell ID, Schofield CJ 2009. Asparaginyl β-hydroxylation of proteins containing ankyrin repeat domains influences their stability and function. J. Mol. Biol. 392:994–1006
    [Google Scholar]
76. 76.  Schmierer B, Novak B, Schofield CJ 2010. Hypoxia-dependent sequestration of an oxygen sensor by a widespread structural motif can shape the hypoxic response—a predictive kinetic model. BMC Syst. Biol. 4:139
    [Google Scholar]
77. 77.  Loenarz C, Sekirnik R, Thalhammer A, Ge W, Spivakovsky E et al. 2014. Hydroxylation of the eukaryotic ribosomal decoding center affects translational accuracy. PNAS 111:4019–24
    [Google Scholar]
78. 78.  Singleton RS, Liu-Yi P, Formenti F, Ge W, Sekirnik R et al. 2014. OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation. PNAS 111:4031–36
    [Google Scholar]
79. 79.  Horita S, Scotti JS, Thinnes C, Mottaghi-Taromsari YS, Thalhammer A et al. 2015. Structure of the ribosomal oxygenase OGFOD1 provides insights into the regio- and stereoselectivity of prolyl hydroxylases. Structure 23:639–52
    [Google Scholar]
80. 80.  Katz MJ, Acevedo JM, Loenarz C, Galagovsky D, Liu-Yi P et al. 2014. Sudestada1, a Drosophila ribosomal prolyl-hydroxylase required for mRNA translation, cell homeostasis, and organ growth. PNAS 111:4025–30
    [Google Scholar]
81. 81.  Bottger A, Islam MS, Chowdhury R, Schofield CJ, Wolf A 2015. The oxygenase Jmjd6—a case study in conflicting assignments. Biochem. J. 468:191–202
    [Google Scholar]
82. 82.  Chang B, Chen Y, Zhao Y, Bruick RK 2007. JMJD6 is a histone arginine demethylase. Science 318:444–47
    [Google Scholar]
83. 83.  Ge W, Wolf A, Feng T, Ho CH, Sekirnik R et al. 2012. Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans. Nat. Chem. Biol. 8:960–62
    [Google Scholar]
84. 84.  van Staalduinen LM, Novakowski SK, Jia Z 2014. Structure and functional analysis of YcfD, a novel 2-oxoglutarate/Fe²⁺-dependent oxygenase involved in translational regulation in Escherichia coli. J. Mol. Biol. 426:1898–910
    [Google Scholar]
85. 85.  Feng T, Yamamoto A, Wilkins SE, Sokolova E, Yates LA et al. 2014. Optimal translational termination requires C4 lysyl hydroxylation of eRF1. Mol. Cell 53:645–54
    [Google Scholar]
86. 86.  Del Rizzo PA, Krishnan S, Trievel RC 2012. Crystal structure and functional analysis of JMJD5 indicate an alternate specificity and function. Mol. Cell Biol. 32:4044–52
    [Google Scholar]
87. 87.  Cheng X, Trievel RC 2015. JmjC lysine demethylases. See Ref. 2 210–45
88. 88.  Couture JF, Trievel RC 2006. Histone-modifying enzymes: encrypting an enigmatic epigenetic code. Curr. Opin. Struct. Biol. 16:753–60
    [Google Scholar]
89. 89.  Thinnes CC, England KS, Kawamura A, Chowdhury R, Schofield CJ, Hopkinson RJ 2014. Targeting histone lysine demethylases—progress, challenges, and the future. Biochim. Biophys. Acta 1839:1416–32
    [Google Scholar]
90. 90.  Walport LJ, Hopkinson RJ, Chowdhury R, Schiller R, Ge W et al. 2016. Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases. Nat. Commun. 7:11974
    [Google Scholar]
91. 91.  Horton JR, Upadhyay AK, Hashimoto H, Zhang X, Cheng X 2011. Structural basis for human PHF2 Jumonji domain interaction with metal ions. J. Mol. Biol. 406:1–8
    [Google Scholar]
92. 92.  Peng JC, Valouev A, Swigut T, Zhang J, Zhao Y et al. 2009. Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 139:1290–302
    [Google Scholar]
93. 93.  Tsukada Y, Ishitani T, Nakayama KI 2010. KDM7 is a dual demethylase for histone H3 Lys 9 and Lys 27 and functions in brain development. Genes Dev 24:432–37
    [Google Scholar]
94. 94.  Zheng G, He C 2015. RNA demethylation by FTO and ALKBH5. See Ref. 2 263–74
95. 95.  Falnes PO, Yen Ho AY 2015. Role of ALKBH8 in the synthesis of wobble uridine modifications in tRNA. See Ref. 2 275–88
96. 96.  Aravind L, Zhang D, Iyer LM 2015. The TET/JBP family of nucleic acid base-modifying 2-oxoglutarate and iron-dependent dioxygenases. See Ref. 2 289–308
97. 97.  Reynolds D, Cliffe L, Sabatini R 2015. 2-Oxoglutarate-dependent hydroxylases involved in DNA Base J (β-d-glucopyranosyloxymethyluracil) synthesis. See Ref. 2 309–23
98. 98.  Thornburg LD, Stubbe J 1993. Mechanism-based inactivation of thymine hydroxylase, an α-ketoglutarate-dependent dioxygenase, by 5-ethynyluracil. Biochemistry 32:14034–42
    [Google Scholar]
99. 99.  Chen K, Zhao BS, He C 2016. Nucleic acid modifications in regulation of gene expression. Cell Chem. Biol. 23:74–85
    [Google Scholar]
100. 100.  Ringvoll J, Nordstrand LM, Vågbø CB, Talstad V, Reite K et al. 2006. Repair deficient mice reveal mABH2 as the primary oxidative demethylase for repairing 1meA and 3meC lesions in DNA. EMBO J 25:2189–98
     [Google Scholar]
101. 101.  Duncan T, Trewick SC, Koivisto P, Bates PA, Lindahl T, Sedgwick B 2002. Reversal of DNA alkylation damage by two human dioxygenases. PNAS 99:16660–65
     [Google Scholar]
102. 102.  Kato M, Araiso Y, Noma A, Nagao A, Suzuki T et al. 2011. Crystal structure of a novel JmjC-domain-containing protein, TYW5, involved in tRNA modification. Nucleic Acids Res 39:1576–85
     [Google Scholar]
103. 103.  Noma A, Ishitani R, Kato M, Nagao A, Nureki O, Suzuki T 2010. Expanding role of the Jumonji C domain as an RNA hydroxylase. J. Biol. Chem. 285:34503–7
     [Google Scholar]
104. 104.  Fu Y, Dai Q, Zhang W, Ren J, Pan T, He C 2010. The AlkB domain of mammalian ABH8 catalyzes hydroxylation of 5-methoxycarbonylmethyluridine at the wobble position of tRNA. Angew. Chem. Int. Ed. 49:8885–88
     [Google Scholar]
105. 105.  van den Born E, Vagbo CB, Songe-Moller L, Leihne V, Lien GF et al. 2011. ALKBH8-mediated formation of a novel diastereomeric pair of wobble nucleosides in mammalian tRNA. Nat. Commun. 2:172
     [Google Scholar]
106. 106.  He YF, Li BZ, Li Z, Liu P, Wang Y et al. 2011. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333:1303–7
     [Google Scholar]
107. 107.  Ito S, Shen L, Dai Q, Wu SC, Collins LB et al. 2011. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333:1300–3
     [Google Scholar]
108. 108.  Pfaffeneder T, Hackner B, Truss M, Munzel M, Muller M et al. 2011. The discovery of 5-formylcytosine in embryonic stem cell DNA. Angew. Chem. Int. Ed. 50:7008–12
     [Google Scholar]
109. 109.  Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H et al. 2009. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324:930–35
     [Google Scholar]
110. 110.  Cliffe LJ, Hirsch G, Wang J, Ekanayake D, Bullard W et al. 2012. JBP1 and JBP2 proteins are Fe²⁺/2-oxoglutarate-dependent dioxygenases regulating hydroxylation of thymidine residues in trypanosome DNA. J. Biol. Chem. 287:19886–95
     [Google Scholar]
111. 111.  Hu L, Li Z, Cheng J, Rao Q, Gong W et al. 2013. Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation. Cell 155:1545–55
     [Google Scholar]
112. 112.  Hara R, Kino K 2009. Characterization of novel 2-oxoglutarate dependent dioxygenases converting l-proline to cis-4-hydroxy-l-proline. Biochem. Biophys. Res. Commun. 379:882–86
     [Google Scholar]
113. 113.  Lawrence CC, Sobey WJ, Field RA, Baldwin JE, Schofield CJ 1996. Purification and initial characterization of proline 4-hydroxylase from Streptomyces griseoviridus P8648: a 2-oxoacid, ferrous-dependent dioxygenase involved in etamycin biosynthesis. Biochem. J. 313:185–91
     [Google Scholar]
114. 114.  Strieker M, Kopp F, Mahlert C, Essen LO, Marahiel MA 2007. Mechanistic and structural basis of stereospecific Cβ-hydroxylation in calcium-dependent antibiotic, a daptomycin-type lipopeptide. ACS Chem. Biol. 2:187–96
     [Google Scholar]
115. 115.  Singh GM, Fortin PD, Koglin A, Walsh CT 2008. Beta hydroxylation of the aspartyl residue in the phytotoxin syringomycin E: characterization of two candidate hydroxylases AspH and SyrP in Pseudomonas syringae. Biochemistry 47:11310–20
     [Google Scholar]
116. 116.  Yin X, Zabriskie TM 2004. VioC is a non-heme iron, α-ketoglutarate-dependent oxygenase that catalyzes the formation of 3S-hydroxy-l-arginine during viomycin biosynthesis. ChemBioChem 5:1274–77
     [Google Scholar]
117. 117.  Smirnov SV, Sokolov PM, Kodera T, Sugiyama M, Hibi M et al. 2012. A novel family of bacterial dioxygenases that catalyse the hydroxylation of free amino acids. FEMS Microbiol. Lett. 331:97–104
     [Google Scholar]
118. 118.  Smirnov SV, Kodera T, Samsonova NN, Kotlyarova VA, Rushkevich NY et al. 2010. Metabolic engineering of Escherichia coli to produce (2S, 3R, 4S)-4-hydroxyisoleucine. Appl. Microbiol. Biotechnol. 88:719–26
     [Google Scholar]
119. 119.  Smirnov SV, Sokolov PM, Kotlyarova VA, Samsonova NN, Kodera T et al. 2013. A novel L-isoleucine-4′-dioxygenase and l-isoleucine dihydroxylation cascade in Pantoea ananatis. MicrobiologyOpen 2:471–81
     [Google Scholar]
120. 120.  Haefele C, Bonfils C, Sauvaire Y 1997. Characterization of a dioxygenase from Trigonella foenum-graecum involved in 4-hydroxyisoleucine biosynthesis. Phytochemistry 44:563–66
     [Google Scholar]
121. 121.  Novak RF, Swift TJ, Hoppel CL 1980. N⁶-Trimethyl-lysine metabolism. Structural identification of the metabolite 3-hydroxy-N⁶-trimethyl-lysine. Biochem. J. 188:521–27
     [Google Scholar]
122. 122.  Haltli B, Tan Y, Magarvey NA, Wagenaar M, Yin X et al. 2005. Investigating β-hydroxyenduracididine formation in the biosynthesis of the mannopeptimycins. Chem. Biol. 12:1163–68
     [Google Scholar]
123. 123.  Bursy J, Pierik AJ, Pica N, Bremer E 2007. Osmotically induced synthesis of the compatible solute hydroxyectoine is mediated by an evolutionarily conserved ectoine hydroxylase. J. Biol. Chem. 282:31147–55
     [Google Scholar]
124. 124.  Fukuda H, Ogawa T, Tazaki M, Nagahama K, Fujii T et al. 1992. Two reactions are simultaneously catalyzed by a single enzyme: the arginine-dependent simultaneous formation of two products, ethylene and succinate, from 2-oxoglutarate by an enzyme from Pseudomonas syringae. Biochem. Biophys. Res. Commun. 188:483–89
     [Google Scholar]
125. 125.  Martinez S, Hausinger RP 2016. Biochemical and spectroscopic characterization of the non-heme Fe(II)- and 2-oxoglutarate-dependent ethylene-forming enzyme from Pseudomonas syringae pv. phaseolicola PK2. Biochemistry 55:5989–99
     [Google Scholar]
126. 126.  Townsend CA. 1997. Structural studies of natural product biosynthetic proteins. Chem. Biol. 4:721–30
     [Google Scholar]
127. 127.  Chang W-C, Guo Y, Wang C, Butch SE, Rosenzweig AC et al. 2014. Mechanism of the C5 stereoinversion reaction in the biosynthesis of carbapenem antibiotics. Science 343:1140–44
     [Google Scholar]
128. 128.  Blasiak LC, Vaillancourt FH, Walsh CT, Drennan CL 2006. Crystal structure of the non-haem iron halogenase SyrB2 in syringomycin biosynthesis. Nature 440:368–71
     [Google Scholar]
129. 129.  Mitchell AJ, Zhu Q, Maggiolo AO, Ananth NR, Hillwig ML et al. 2016. Structural basis for halogenation by iron- and 2-oxo-glutarate-dependent enzyme WelO5. Nat. Chem. Biol. 12:636–40
     [Google Scholar]
130. 130.  Hedden P, Phillips AL 2015. Gibberellin metabolism. See Ref. 2 367–84
131. 131.  Martens S, Matern U 2015. Role of 2-oxoglutarate-dependent oxygenases in flavonoid metabolism. See Ref. 2 350–66
132. 132.  Peiser GD, Wang TT, Hoffman NE, Yang SF, Liu HW, Walsh CT 1984. Formation of cyanide from carbon 1 of 1-aminocyclopropane-1-carboxylic acid during its conversion to ethylene. PNAS 81:3059–63
     [Google Scholar]
133. 133.  Zhang Z, Ren JS, Clifton IJ, Schofield CJ 2004. Crystal structure and mechanistic implications of 1-aminocyclopropane-1-carboxylic acid oxidase—the ethylene-forming enzyme. Chem. Biol. 11:1383–94
     [Google Scholar]
134. 134.  Fukumori F, Hausinger RP 1993. Alcaligenes eutrophus JMP134 “2,4-dichlorophenoxyacetate monooxygenase” is an alpha-ketoglutarate-dependent dioxygenase. J. Bacteriol. 175:2083–86
     [Google Scholar]
135. 135.  Jakubczyk D, Caputi L, Hatsch A, Nielsen CA, Diefenbacher M et al. 2015. Discovery and reconstitution of the cycloclavine biosynthetic pathway—enzymatic formation of a cyclopropyl group. Angew. Chem. Int. Ed. 54:5117–21
     [Google Scholar]
136. 136.  Wanders RJA, Ferdinandusse S, Ebberink MS, Waterham HR 2015. Phytanoyl-CoA hydroxylase: a 2-oxoglutarate-dependent dioxygenase crucial for fatty acid alpha-oxidation in humans. See Ref. 2 338–49
137. 137.  Tars K, Leitans J, Kazaks A, Zelencova D, Liepinsh E et al. 2014. Targeting carnitine biosynthesis: discovery of new inhibitors against γ-butyrobetaine hydroxylase. J. Med. Chem. 57:2213–36
     [Google Scholar]
138. 138.  Vinogradova M, Gehling VS, Gustafson A, Arora S, Tindell CA et al. 2016. An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells. Nat. Chem. Biol. 12:531–38
     [Google Scholar]
139. 139.  Henry L, Leung IK, Claridge TD, Schofield CJ 2012. γ-Butyrobetaine hydroxylase catalyses a Stevens type rearrangement. Bioorg. Med. Chem. Lett. 22:4975–78
     [Google Scholar]
140. 140.  Leung IK, Krojer TJ, Kochan GT, Henry L, von Delft F et al. 2010. Structural and mechanistic studies on γ-butyrobetaine hydroxylase. Chem. Biol. 17:1316–24
     [Google Scholar]
141. 141.  Rydzik AM, Chowdhury R, Kochan GT, Williams ST, McDonough MA et al. 2014. Modulating carnitine levels by targeting its biosynthesis pathway—selective inhibition of γ-butyrobetaine hydroxylase. Chem. Sci. 5:1765–71
     [Google Scholar]
142. 142.  Leung IK, Demetriades M, Hardy AP, Lejeune C, Smart TJ et al. 2013. Reporter ligand NMR screening method for 2-oxoglutarate oxygenase inhibitors. J. Med. Chem. 56:547–55
     [Google Scholar]
143. 143.  Rydzik AM, Leung IK, Kochan GT, Thalhammer A, Oppermann U et al. 2012. Development and application of a fluoride-detection-based fluorescence assay for γ-butyrobetaine hydroxylase. ChemBioChem 13:1559–63
     [Google Scholar]
144. 144.  Hopkinson RJ, Tumber A, Yapp C, Chowdhury R, Aik W et al. 2013. 5-Carboxy-8-hydroxyquinoline is a broad spectrum 2-oxoglutarate oxygenase inhibitor which causes iron translocation. Chem. Sci. 4:3110–17
     [Google Scholar]
145. 145.  Rabinowitz MH. 2013. Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses. J. Med. Chem. 56:9369–402
     [Google Scholar]
146. 146.  Wilkins SE, Flashman E, Scotti JS, Hopkinson RJ, Chowdhury R, Schofield CJ 2015. The role of 2-oxoglutarate-dependent oxygenases in hypoxia sensing. See Ref. 2 169–209
147. 147.  Chan MC, Atasoylu O, Hodson E, Tumber A, Leung IK et al. 2015. Potent and selective triazole-based inhibitors of the hypoxia-inducible factor prolyl-hydroxylases with activity in the murine brain. PLOS ONE 10:e0132004
     [Google Scholar]
148. 148.  Schuster SJ, Badiavas EV, Costa-Giomi P, Weinmann R, Erslev AJ, Caro J 1989. Stimulation of erythropoietin gene transcription during hypoxia and cobalt exposure. Blood 73:13–16
     [Google Scholar]
149. 149.  Wolf J, Levy IJ 1954. Treatment of sickle cell anemia with cobalt chloride. AMA Arch. Intern. Med. 93:387–96
     [Google Scholar]
150. 150.  Rademacher W. 2000. Growth retardants: effects on gibberellin biosynthesis and other metabolic pathways. Annu. Rev. Plant Physiol. Plant Mol. Biol. 51:501–31
     [Google Scholar]
151. 151.  Hedden P. 2003. The genes of the Green Revolution. Trends Genet 19:5–9
     [Google Scholar]
152. 152.  Rose NR, Woon EC, Tumber A, Walport LJ, Chowdhury R et al. 2012. Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases. J. Med. Chem. 55:6639–43
     [Google Scholar]
153. 153.  Shah DD, Moran GR 2015. 4-Hydroxyphenylpyruvate dioxygenase and hydroxymandelate synthase: 2-oxo acid-dependent oxygenases of importance to agriculture and medicine. See Ref. 2 438–57
154. 154.  Lindstedt S, Holme E, Lock EA, Hjalmarson O, Strandvik B 1992. Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 340:813–17
     [Google Scholar]
155. 155.  McAllister TE, England KS, Hopkinson RJ, Brennan PE, Kawamura A, Schofield CJ 2016. Recent progress in histone demethylase inhibitors. J. Med. Chem. 59:1308–29
     [Google Scholar]
156. 156.  Kawamura A, Münzel M, Kojima T, Yapp C, Bhushan B et al. 2017. Highly selective inhibition of histone demethylases by de novo macrocyclic peptides. Nature Commun 8:14773
     [Google Scholar]
157. 157.  Chowdhury R, Yeoh KK, Tian YM, Hillringhaus L, Bagg EA et al. 2011. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep 12:463–69
     [Google Scholar]
158. 158.  Flavahan WA, Drier Y, Liau BB, Gillespie SM, Venteicher AS et al. 2016. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529:110–14
     [Google Scholar]
159. 159.  Xu W, Yang H, Liu Y, Yang Y, Wang P et al. 2011. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 19:17–30
     [Google Scholar]
160. 160.  Koivunen P, Lee S, Duncan CG, Lopez G, Lu G et al. 2012. Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483:484–88
     [Google Scholar]
161. 161.  Tarhonskaya H, Rydzik AM, Leung IK, Loik ND, Chan MC et al. 2014. Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases. Nat. Commun. 5:3423
     [Google Scholar]
162. 162.  Shibasaki T, Mori H, Ozaki A 2000. Enzymatic production of trans-4-hydroxy-l-proline by regio- and stereospecific hydroxylation of l-proline. Biosci. Biotechnol. Biochem. 64:746–50
     [Google Scholar]
163. 163.  Zafar MI, Gao F 2016. 4-Hydroxyisoleucine: a potential new treatment for type 2 diabetes mellitus. BioDrugs 30:255–62
     [Google Scholar]
164. 164.  Lin B, Fan K, Zhao J, Ji J, Wu L et al. 2015. Reconstitution of TCA cycle with DAOCS to engineer Escherichia coli into an efficient whole cell catalyst of penicillin G. PNAS 112:9855–59
     [Google Scholar]
165. 165.  Queener SW. 1990. Molecular biology of penicillin and cephalosporin biosynthesis. Antimicrob. Agents Chemother. 34:943–48
     [Google Scholar]
166. 166.  Balakrishnan N, Ganesan S, Rajasekaran P, Rajendran L, Teddu S, Durairaaj M 2016. Modified deacetylcephalosporin C synthase for the biotransformation of semisynthetic cephalosporins. Appl. Environ. Microbiol. 82:3711–20
     [Google Scholar]
167. 167.  Yang M, Hardy AP, Chowdhury R, Loik ND, Scotti JS et al. 2013. Substrate selectivity analyses of factor inhibiting hypoxia-inducible factor. Angew. Chem. Int. Ed. 52:1700–4
     [Google Scholar]
168. 168.  Allpress CJ, Kleespies ST, Que L Jr 2015. Synthetic models of 2-oxoglutarate-dependent oxygenases. See Ref. 2 123–48
169. 169.  Que L Jr, Tolman WB. 2008. Biologically inspired oxidation catalysis. Nature 455:333–40
     [Google Scholar]